Cargando…
Relacin, a Novel Antibacterial Agent Targeting the Stringent Response
Finding bacterial cellular targets for developing novel antibiotics has become a major challenge in fighting resistant pathogenic bacteria. We present a novel compound, Relacin, designed to inhibit (p)ppGpp production by the ubiquitous bacterial enzyme RelA that triggers the Stringent Response. Rela...
Autores principales: | Wexselblatt, Ezequiel, Oppenheimer-Shaanan, Yaara, Kaspy, Ilana, London, Nir, Schueler-Furman, Ora, Yavin, Eylon, Glaser, Gad, Katzhendler, Joshua, Ben-Yehuda, Sigal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447753/ https://www.ncbi.nlm.nih.gov/pubmed/23028324 http://dx.doi.org/10.1371/journal.ppat.1002925 |
Ejemplares similares
-
Escherichia coli RelA Regulation via Its C-Terminal Domain
por: Kaspy, Ilana, et al.
Publicado: (2020) -
Efficacy of relacin combined with sodium hypochlorite against Enterococcus faecalis biofilms
por: Yanling, CAI, et al.
Publicado: (2018) -
Micro-CT X-ray imaging exposes structured diffusion barriers within biofilms
por: Keren-Paz, Alona, et al.
Publicado: (2018) -
Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors
por: Raveh, Barak, et al.
Publicado: (2011) -
Rosetta FlexPepDock web server—high resolution modeling of peptide–protein interactions
por: London, Nir, et al.
Publicado: (2011)